StockWatch
·
Pharmaceuticals
Board Meeting15 Oct 2026, 10:29 am

Ajanta Pharma Board Meeting on Oct 30 to Approve Q2 FY27 Results

AI Summary

Ajanta Pharma Ltd has announced that its Board of Directors will convene on October 30, 2026. The primary agenda for this meeting is to consider and approve the unaudited consolidated and standalone financial results for the second quarter and half-year period ending September 30, 2026. This announcement is made in compliance with Regulation 29 of the Listing Regulations.

Key Highlights

  • Board meeting scheduled for October 30, 2026.
  • To approve unaudited financial results.
  • Covers second quarter and half-year ended September 30, 2026.
  • Consolidated and standalone results will be reviewed.